Company Search:
Advanced Search
Sponsored Links
Brainjuicer Group Plc Company Snapshot
Brainjuicer Group Plc operates in the Commercial nonphysical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Brainjuicer Group Plc with three other miscellaneous service companies in Europe: DocCheck AG of Germany (2015 sales of 26.80 million Euro [US$28.73 million] ), Alligator Bioscience Ab of Sweden (289.80 million Swedish Kronor [US$32.62 million] ), and Molecular Partners AG which is based in Switzerland (29.12 million Swiss Francs [US$29.06 million] of which 100% was Biopharmaceuticals).

Sales Analysis. Brainjuicer Group Plc reported sales of £25.18 million (US$31.25 million) for the year ending December of 2015. This represents an increase of 2.2% versus 2014, when the company's sales were £24.65 million. Sales at Brainjuicer Group Plc have increased during each of the previous five years (and since 2010, sales have increased a total of 54%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Brainjuicer Group Plc
  Stock Performance Chart for Brainjuicer Group Plc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 565.00p
(Figures in Pounds Sterling)
1 Week 2.7%   13 Weeks 4.8%  
4 Weeks 12.4%   52 Weeks 64.0%  
Brainjuicer Group Plc Key Data:
  Ticker: BJU Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Nonphysical Research
  2015 Sales 25,184,000
(Year Ending Jan 2016).
Employees: 158
  Currency: Pounds Sterling Market Cap: 69,027,615
  Fiscal Yr Ends: December Shares Outstanding: 12,217,277
  Share Type: Ordinary Closely Held Shares: 4,014,430
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.